Kai Xu

1.6k total citations
75 papers, 1.3k citations indexed

About

Kai Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kai Xu has authored 75 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Kai Xu's work include Epigenetics and DNA Methylation (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and RNA modifications and cancer (5 papers). Kai Xu is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and RNA modifications and cancer (5 papers). Kai Xu collaborates with scholars based in China, Bangladesh and United States. Kai Xu's co-authors include Yuepu Pu, Rongli Sun, Juan Zhang, Yunqiu Pu, Lihong Yin, Jiawei Huang, Fei Xiong, Jinyan Liu, Manman Liu and Fujian Ni and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and The Science of The Total Environment.

In The Last Decade

Kai Xu

72 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Xu China 21 406 234 172 171 125 75 1.3k
Yu Sun China 27 1.1k 2.6× 233 1.0× 229 1.3× 174 1.0× 182 1.5× 77 2.3k
Tingting Qian China 23 709 1.7× 126 0.5× 329 1.9× 282 1.6× 69 0.6× 93 1.8k
Beilei Wang China 19 763 1.9× 166 0.7× 209 1.2× 165 1.0× 54 0.4× 42 1.5k
Jin Fu China 20 307 0.8× 258 1.1× 117 0.7× 104 0.6× 103 0.8× 74 1.2k
Chunlei Chen China 21 657 1.6× 208 0.9× 87 0.5× 97 0.6× 33 0.3× 47 1.3k
Yang Lv China 18 307 0.8× 159 0.7× 56 0.3× 85 0.5× 82 0.7× 48 1.2k
Xing Wan China 21 638 1.6× 123 0.5× 124 0.7× 66 0.4× 120 1.0× 64 1.5k
Ying Yu China 25 851 2.1× 246 1.1× 190 1.1× 348 2.0× 29 0.2× 102 2.2k
Zhiyuan Lv China 20 406 1.0× 169 0.7× 142 0.8× 298 1.7× 273 2.2× 41 1.3k
Hui He China 20 526 1.3× 249 1.1× 193 1.1× 87 0.5× 34 0.3× 60 1.3k

Countries citing papers authored by Kai Xu

Since Specialization
Citations

This map shows the geographic impact of Kai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Xu more than expected).

Fields of papers citing papers by Kai Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Xu. The network helps show where Kai Xu may publish in the future.

Co-authorship network of co-authors of Kai Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Xu. A scholar is included among the top collaborators of Kai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Xu. Kai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Pengcheng, Yu Zou, Xin Wang, et al.. (2025). NSun2‐Mediated tsRNAs Alleviate Liver Fibrosis via FAK Dephosphorylation. Cell Proliferation. 58(10). e70058–e70058. 2 indexed citations
3.
Xu, Kai, María Dolores Frutos, María Ángeles Núñez‐Sánchez, et al.. (2025). Hepatic HKDC1 deletion alleviates western diet-induced MASH in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(4). 167746–167746. 1 indexed citations
4.
Zhang, Cancan, Yinyin Xu, Xueli Zhang, et al.. (2024). Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a positive feedback manner in ovarian cancer. Oncogene. 43(26). 1985–1999. 3 indexed citations
5.
Xu, Kai, Jingxuan Wei, Dan Su, et al.. (2024). Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe. International Journal of Clinical Pharmacy. 47(1). 196–209. 1 indexed citations
6.
Liu, Manman, Jinyan Liu, Fei Xiong, et al.. (2023). Research advances of microplastics and potential health risks of microplastics on terrestrial higher mammals: a bibliometric analysis and literature review. Environmental Geochemistry and Health. 45(6). 2803–2838. 46 indexed citations
7.
Sun, Rongli, Kai Xu, Yunqiu Pu, et al.. (2022). Evi1 involved in benzene-induced haematotoxicity via modulation of PI3K/mTOR pathway and negative regulation Serpinb2. Chemico-Biological Interactions. 354. 109836–109836. 3 indexed citations
8.
Wang, Boshen, Tong Wang, Kai Xu, et al.. (2021). LincRNA-p21 promotes p21-mediated cell cycle arrest in benzene-induced hematotoxicity by sponging miRNA-17-5p. Environmental Pollution. 296. 118706–118706. 14 indexed citations
9.
Sun, Rongli, Kai Xu, Yunqiu Pu, et al.. (2020). Toxicity in hematopoietic stem cells from bone marrow and peripheral blood in mice after benzene exposure: Single-cell transcriptome sequencing analysis. Ecotoxicology and Environmental Safety. 207. 111490–111490. 33 indexed citations
10.
Pan, Haiyan, Yuanyuan Mi, Kai Xu, et al.. (2020). Association of C‐reactive protein (CRP) rs1205 and rs2808630 variants and risk of cancer. Journal of Cellular Physiology. 235(11). 8571–8584. 7 indexed citations
11.
Feng, Qin, Kai Xu, Ze Zhang, et al.. (2020). XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma. Medicine. 99(28). e21160–e21160. 3 indexed citations
12.
Zhang, Wei, Ze Zhang, Hao Wu, et al.. (2020). Update analysis on the association between Methionine synthase rs1805087 A/G variant and risk of prostate cancer. Scientific Reports. 10(1). 13384–13384. 5 indexed citations
13.
Shan, Xiaojun, et al.. (2019). Correlations of breast cancer FHIT gene with the incidence and prognosis of breast cancer.. PubMed. 24(1). 40–47. 3 indexed citations
14.
15.
Zhang, Yangjun, et al.. (2016). Research Progress in Pharmacologic Action and Mechanism of Ginseng Radix et Rhizoma Extract for Treating Alzheimer's Disease. 23(9). 129. 1 indexed citations
16.
Wang, Kaituo, Peng Jin, Lin Han, et al.. (2014). Methyl jasmonate induces resistance against Penicillium citrinum in Chinese bayberry by priming of defense responses. Postharvest Biology and Technology. 98. 90–97. 99 indexed citations
17.
Xu, Kai. (2012). Therapeutic Observation on Electroacupuncture for Cervical Vertigo. Shanghai zhenjiu zazhi. 2 indexed citations
18.
Xu, Kai. (2010). Observations on the Efficacy of Thunder-fire Moxibustion in Treating Gastralgia of Deficiency Cold Type. Shanghai zhenjiu zazhi. 1 indexed citations
19.
Zhu, Qi, Kai Xu, Hui Fu, et al.. (2008). EUS-guided oncolytic adenovirus implantation in patients of non-operative pancreatic cancer. Zhonghua xiaohua neijing zazhi. 25(7). 341–346. 1 indexed citations
20.
Xu, Kai. (2006). Radiotherapy combined with concomitant chemotherapy for stage III non-small cell lung cancer. Zhonghua zhongliu fangzhi zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026